Biomarkers of Air-Blood Barrier Damage In COVID-19

Biomarkers of Air-Blood Barrier Damage In COVID-19

The search for sensitive and specific markers enabling timely identification of patients with a life-threatening novel coronavirus infection (COVID-19) is important for a successful treatment.The aim of the study was to examine the association of molecular biomarkers of air-blood barrier damage, sur...

Full description

Bibliographic Details
Main Authors: M. B. Khadzhieva, A. S. Gracheva, A. V. Ershov, Yu. V. Chursinova, V. A. Stepanov, L. S. Avdeikina, O. A. Grebenchikov, A. S. Babkina, A. K. Shabanov, A. V. Tutelyan, S. S. Petrikov, A. N. Kuzovlev
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2021-07-01
Series:Общая реаниматология
Subjects:
сурфактантный белок sp-a
сурфактантный белок sp-d
белок клеток клара cc16
covid-19
Online Access:https://www.reanimatology.com/rmt/article/view/2075

Similar Items

Similar Items